Diamond Industries Limited (PSX:DIIL)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	311	225	315	222	222	222
Market Cap Growth	23.65%	-28.49%	42.05%	-	-	-
Enterprise Value	446	362	312	357	218	355
Last Close Price	34.58	25.03	35.00	24.64	24.64	24.64
PE Ratio	-	-	-	4.19	6.62	981.81
PS Ratio	19.47	-	0.33	0.12	1.36	24.03
PB Ratio	1.76	0.91	1.36	0.77	0.91	1.18
P/TBV Ratio	1.76	0.91	1.36	0.77	0.91	1.18
EV/Sales Ratio	27.93	-	0.33	0.20	1.34	38.50
EV/EBITDA Ratio	-	-	-	4.56	11.32	-
EV/EBIT Ratio	-	-	-	5.22	20.70	-
Debt / Equity Ratio	0.78	0.56	0.59	0.48	0.56	0.73
Debt / EBITDA Ratio	-	-	-	1.75	7.12	-
Asset Turnover	0.03	-	1.41	2.36	0.32	0.02
Inventory Turnover	1.98	-	3.57	6.24	-	-
Quick Ratio	0.03	0.03	0.02	0.45	0.45	0.24
Current Ratio	0.53	2.06	2.14	1.52	1.71	4.11
Return on Equity (ROE)	-72.59%	-10.14%	-16.85%	19.97%	15.53%	0.13%
Return on Assets (ROA)	-20.64%	-2.90%	-2.71%	5.66%	1.27%	-2.00%
Return on Capital (ROIC)	-29.29%	-3.94%	-4.66%	10.63%	1.86%	-2.48%
Return on Capital Employed (ROCE)	-	-	-	13.70%	2.30%	-
Earnings Yield	-48.03%	-10.76%	-13.86%	23.86%	15.11%	0.10%
FCF Yield	-	-4.92%	-0.94%	-2.97%	-13.49%	-5.41%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.